Latest Breaking News On - Executive chairman mike grey - Page 1 : comparemela.com

Reneo Pharmaceuticals Inc., which announced in December the failure of its drug to treat rare genetic diseases, said it will be acquired by OnKure Inc., a Boulder, Colo.-based privately held biopharmaceutical company.

San diegoUnited statesOrange countyGregory flesherNicholas saccomanoReneo pharmaceuticals incOnkure therapeutics incOnkure incOnkure therapeuticsExecutive chairman mike greyChief executive gregory flesherBusiness journalAcorn bioventuresCormorant asset managementDeep track capitalPerceptive advisors